Relay Therapeutics (RLAY)

• Market cap: $1.3B
• 1 day: -2.46%
• 5 days: -1.96%
• 1 month: -9.94%
• 3 months: 2.45%
• 6 months: 107.16%
• Year to date: -8.07%
• 1 year: 65.64%
• 5 years: -85.12%
• 10 years: -78.54%
• Sector: Healthcare
• Industry: Biotechnology

About: Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Employees: 197